Lv3
388 积分 2021-01-23 加入
合并大血管侵犯肝细胞癌外科治疗的争议与共识
20天前
已完结
Announcing the Lancet Commission on colorectal cancer: addressing the rising global burden
1个月前
已完结
Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer
1个月前
已完结
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial
1个月前
已完结
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial
1个月前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
2个月前
已完结
Claudin proteins as emerging therapeutic targets for solid tumours
2个月前
已完结
Gastric Cancer: A Review
2个月前
已完结
Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649
2个月前
已完结
Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer
2个月前
已完结
皖公网安备34019202002308
